Search Results 51-60 of 17102 for nivolumab

1. Anti-Lag-3 (Relatlimab) And Anti-PD-1 Blockade (Nivolumab) Versus Standard Of Care (Lomustine) For The Treatment Of Patients With Recurrent Glioblastoma - Mayo Clinic

   Relatlimab and nivolumab are monoclonal antibodies that may interfere with the ability of tumor cells to grow and spread. Lomustine is a chemotherapy drug and ...

2. A Study Of Investigational Immunotherapy To Determine The Safety And Effectiveness Of Nivolumab And Daratumumab, With Or Without Pomalidomide And Dexamethasone, In Patients With Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   The purpose of this study is to determine the side effects of treatment with Nivolumab by itself or in combination in patients with relapsed/refractory ...

3. Ivosidenib, Nivolumab, And Ipilimumab Combination In Previously Treated Subjects With Nonresectable Or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

   Ivosidenib, Nivolumab, And Ipilimumab Combination In Previously Treated Subjects With Nonresectable Or Metastatic IDH1-Mutant Cholangiocarcinoma · Overview.

4. Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or Metastatic Melanoma (CheckMate 218) - Mayo Clinic

   Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or ...

5. Trial Of Measles Virotherapy In Combination With Nivolumab In Patients With Metastatic Non-Small Cell Lung Cancer - Mayo Clinic

   This a Phase 1 study designed to determine the maximum tolerated dose (MTD) and toxicity of attenuated Measles virus (MV-NIS) combined with nivolumab in ...

6. A Study To Compare CMP-001 Combined With Nivolumab To Nivolumab Alone In Advanced Melanoma Subjects - Mayo Clinic

   The purpose of this two-phase study is to compare CMP-001 intratumoral (IT) and nivolumab intravenous (IV) compared to nivolumab monotherapy administered to ...

7. Study Of Nivolumab In Subjects With Relapsed Or Refractory Follicular Lymphoma (FL) (CheckMate 140) - Mayo Clinic

   The purpose of this study is to assess the clinical benefit of Nivolumab, as measured by independent radiologic review committee (IRRC)-assessed objective ...

8. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

   Monoclonal antibodies, such as varlilumab and nivolumab, may work by stimulating the immune system to attack cancer tumor cells. Participation eligibility.

9. A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer - Mayo Clinic

   The purpose of this study is to determine whether an investigational immuno-therapy, cabiralizumab in combination with nivolumab, with or without chemotherapy, ...

10. Etigilimab and Nivolumab in Subjects With Locally Advanced or Metastatic Tumors - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness, safety, tolerability, PK, and pharmacodynamics of etigilimab in combination with nivolumab in ...